Deutetrabenazine 

氘代丁苯那嗪

Report date: 2025/02/28 11:25:18
NME

Base Information

Drug NameDeutetrabenazine 
Drug Alias NameDeutetrabenazina氘丁苯那嗪DeutetrabenazinumD6-TetrabenazineAustedo +[10] 
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Deuterated drugs
Mechanisms of ActionSynaptic vesicular amine transporter inhibitors
TargetsSynaptic vesicular amine transporter
Therapy Area/IndicationsDystoniaTardive DyskinesiaChorea +[6] 
Global Approved IndicationsTardive DyskinesiaChoreaHuntington Disease
Approved Indications in ChinaTardive DyskinesiaHuntington Disease
Original Approved Country/TerritoryUnited States
Original Approved Date2017/04/03
Country/TerritoryCzechiaBelgiumCanada +[24] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTeva Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTeva GmbhTeva Branded Pharmaceutical Products R&D IncAnesta Llc +[4] 
Inactive CompaniesFundacion Huntington Puerto RicoVanderbilt University Medical CenterAuspex Pharmaceuticals Inc +[4] 
Active IndicationsDystoniaTardive DyskinesiaChorea +[5] 
Inactive IndicationsTourette Syndrome

Other Information

ATC CodeN07XX06
Related LinksWikipediaDrugBankKEGG